Clofibrate, a lipid lowering agent inhibits both cholesterol and triglyceride synthesis by:: (A) Inhibiting HMG CoA reductase, (B) Binding to bile acids and preventing its reabsorption, (C) Inhibiting VLDL production, (D) Activating lipoprotein lipase, resulting in VLDL degradation
Answer is D. None